Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New school program aims to catch teen mental health issues early

NCT ID NCT04935710

Knowledge-focused Sponsor: Cambridge Health Alliance Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Sep 18, 2026 · Updated 2 times

Summary

This study tested a program called COPE2Thrive, which uses cognitive behavioral therapy to help teens manage anxiety, stress, and depression. It was offered in school-based clinics to high school students from diverse communities. The goal was to see if this approach could improve early identification and support for mental health issues. The study included 39 teens and used computerized adaptive testing to measure symptoms.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
COPE2Thrive (cognitive behavioral therapy-based program)
What this could lead to
If successful, this approach could help schools better identify and support teens at risk for mental health issues, especially in underserved communities.
What could go wrong
This was a small, early-stage study with only 39 participants, so results may not apply broadly. The intervention is behavioral, not a medical treatment, and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

39 people

The number who actually took part.

Started

Jan 2022

Finished

Mar 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 24 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* High school students in CHA's catchment area (Cambridge, Chelsea, Everett, Malden, Revere, Somerville, Winthrop) * Youth who are fluent in English, Haitian Creole, Portuguese, or Spanish. * Youth who experience at least some symptoms, defined as a K-CAT-S score (from Aim 1) of moderate on at least one diagnosis with at least mild functional impairment. Patients with more severe symptoms or functional impairment or who do not meet the exclusion criteria are also eligible. Inclusion Criteria for COPE2Thrive: * High school students in CHA's catchment area (Cambridge, Chelsea, Everett, Malden, Revere, Somerville, Winthrop) * Youth who are fluent in English, Haitian-Creole, Portuguese, or Spanish. * Youth who have completed WFIRS and K-CAT, and who do not meet the exclusion criteria. Exclusion Criteria: * 12th-graders will be excluded from the COPE2Thrive program since the participants will not be available for the study's duration. * Students who are already receiving behavioral health care. * Students who are considered to be seriously suicidal and in need of urgent care, in which case the participants would be ineligible based on the fact that the participants will be receiving behavioral health care.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adolescent well being are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adolescent well being Community mental health services Health equity Resilience, psychological Screening

Contacts and locations

Locations

  • CHA Health Equity Research Lab

    Cambridge, Massachusetts, 02141-1047, United States

  • CHA Teen Connections at Somerville High School

    Somerville, Massachusetts, 02143-1740, United States

  • CHA Teen Health Center at Everett High School

    Everett, Massachusetts, 02149-5128, United States

  • CHA-Teen Health Center at Cambridge Rindge and Latin School

    Cambridge, Massachusetts, 02138-4125, United States

  • Community

    Cambridge, Massachusetts, 02141, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.